Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis
- PMID: 8460060
- DOI: 10.1203/00006450-199303000-00008
Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis
Abstract
Plasma antioxidant status and total radical-trapping antioxidant potential (TRAP) of children (n = 24) with cystic fibrosis (CF) were compared with those of children (n = 21) without the disease. Children with CF were found to have elevated plasma concentrations of ascorbic acid (94.6 +/- 58.2 mumol/L), with respect to normal children (65.6 +/- 18.8 mumol/L). Plasma uric acid (330.8 +/- 84 versus 198.0 +/- 31 mumol/L p < 0.01) and sulfhydryl group (518 +/- 43 versus 363 +/- 31 mumol/L p < 0.01) concentrations were also elevated in CF. Vitamin E levels (16.9 +/- 1.8 versus 18.4 +/- 1.3 mumol/L) were at the low end of the normal range. Despite an overall increased antioxidant array, CF patients had a reduced TRAP capacity (488 +/- 34 versus 580 +/- 79 mumol/L, p < 0.05). TRAP measurements in CF patients showed a strong negative correlation (r = 0.80, p < 0.001) with high ascorbic acid concentration, suggesting a prooxidant effect of ascorbic acid. Oral administration of ascorbic acid to adults was found to diminish TRAP activity. Concentrations of ascorbic acid similar to those seen in CF patients were attained in ascorbate-supplemented individuals, with substantial decreases in TRAP capacity. These studies suggest that high plasma ascorbic acid levels in children with CF may have a prooxidant effect. This appears to reduce the extracellular antioxidant defense of these children and may increase susceptibility to oxidative stress.
Similar articles
-
Evidence for increased oxidative damage in patients with cystic fibrosis.Pediatr Res. 1994 Oct;36(4):487-93. doi: 10.1203/00006450-199410000-00013. Pediatr Res. 1994. PMID: 7816524 Clinical Trial.
-
Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis.Int J Vitam Nutr Res. 1998;68(2):83-7. Int J Vitam Nutr Res. 1998. PMID: 9565821 Clinical Trial.
-
Total radical-trapping antioxidant potential (TRAP) of plasma: effects of supplementation of young healthy volunteers with large doses of alpha-tocopherol and ascorbic acid.Int J Vitam Nutr Res. 1993;63(1):27-30. Int J Vitam Nutr Res. 1993. PMID: 8320055 Clinical Trial.
-
Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance.Acta Paediatr Suppl. 1994 Apr;83(395):49-57. doi: 10.1111/j.1651-2227.1994.tb13229.x. Acta Paediatr Suppl. 1994. PMID: 8025360 Review.
-
The antioxidants of human extracellular fluids.Arch Biochem Biophys. 1990 Jul;280(1):1-8. doi: 10.1016/0003-9861(90)90510-6. Arch Biochem Biophys. 1990. PMID: 2191627 Review.
Cited by
-
The role of vitamins in cystic fibrosis.J R Soc Med. 2000;93 Suppl 38(Suppl 38):14-9. J R Soc Med. 2000. PMID: 10911814 Free PMC article. Review. No abstract available.
-
Oxidative stress during acute respiratory exacerbations in cystic fibrosis.Thorax. 1999 Jun;54(6):518-23. doi: 10.1136/thx.54.6.518. Thorax. 1999. PMID: 10335006 Free PMC article.
-
Inflammation in cystic fibrosis.Mediators Inflamm. 1996;5(2):121-43. doi: 10.1155/S096293519600021X. Mediators Inflamm. 1996. PMID: 18475710 Free PMC article. No abstract available.
-
L'inflammation dans la Mucoviscidose.Mediators Inflamm. 1996;5(2):144-69. doi: 10.1155/S0962935196000221. Mediators Inflamm. 1996. PMID: 18475711 Free PMC article. No abstract available.
-
Mapping the oxidative landscape in cystic fibrosis: methodological frontiers and application.Front Pharmacol. 2025 Jul 16;16:1632924. doi: 10.3389/fphar.2025.1632924. eCollection 2025. Front Pharmacol. 2025. PMID: 40740993 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical